Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2020

May 6, 2020

284_dirs_2020-05-06_a8985ed2-2b4c-4c20-b473-97ec9d3777dc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2020-05-04

Reporting Person: Fleming Michael (SVP Chief Ethics & Com Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-04 Common Stock M 692 $77.67 Acquired 6252.334 Direct
2020-05-04 Common Stock F 238 $77.67 Disposed 6014.334 Direct
2020-05-05 Common Stock M 1290 $76.86 Acquired 7304.334 Direct
2020-05-05 Common Stock F 458 $76.86 Disposed 6846.334 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-05-04 Restricted Stock Unit $ M 692 Disposed 2021-05-04 Common Stock (692) Direct
2020-05-05 Restricted Stock Unit $ M 1290 Disposed 2020-05-05 Common Stock (1290) Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F3: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.